The Cicada variant of COVID-19, a highly mutated strain known as BA.3.2, is rapidly spreading across the United States, posing new challenges to public health as it circulates in at least 25 states.
Symptoms associated with the Cicada variant include a severe sore throat, described as "razorblade throat," along with other flu-like signs that may often go unnoticed.
Health experts warn that this variant may escape the protection offered by vaccinations or previous infections, raising significant concerns about its potential impact.
Public health officials urge heightened vigilance, particularly for vulnerable populations, and recommend booster vaccinations to mitigate risks.
The Cicada variant could disproportionately affect children, leading to increased scrutiny and targeted measures to protect young individuals from infection.
As health authorities continuously monitor the situation, they emphasize the importance of distinguishing between COVID-19, flu, and RSV symptoms, promoting awareness and proactive health behaviors in the community.